Causes and methods of preventing cytokine storm in immuno-oncology

Cytokine storm is an excessive immune response that can occur when using immunotherapy in oncology, especially in the case of the use of immune checkpoint inhibitors and other methods that enhance immune activity. The main causes of cytokine storm are hyperactivation of the immune system associated with excessive production of proinflammatory cytokines, which can lead to severe systemic inflammatory reactions and organ damage. Among the methods of preventing cytokine storm, careful selection and monitoring of therapy, the use of immunomodulators, as well as the development of biomarkers to predict the risk of its occurrence are distinguished. The use of combined therapeutic approaches, as well as monitoring the condition of patients and prompt response to early signs of an inflammatory reaction are key strategies in reducing the risk of developing a cytokine storm in immuno-oncology.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-30
DOI
https://doi.org/10.5281/zenodo.14967053
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Causes and methods of preventing cytokine storm in immuno-oncology

Zenodo (CERN European Organization for Nuclear Research)
Cancer Immunotherapy and Biomarkers
article

Causes and methods of preventing cytokine storm in immuno-oncology

article en

Abstract

Cytokine storm is an excessive immune response that can occur when using immunotherapy in oncology, especially in the case of the use of immune checkpoint inhibitors and other methods that enhance immune activity. The main causes of cytokine storm are hyperactivation of the immune system associated with excessive production of proinflammatory cytokines, which can lead to severe systemic inflammatory reactions and organ damage. Among the methods of preventing cytokine storm, careful selection and monitoring of therapy, the use of immunomodulators, as well as the development of biomarkers to predict the risk of its occurrence are distinguished. The use of combined therapeutic approaches, as well as monitoring the condition of patients and prompt response to early signs of an inflammatory reaction are key strategies in reducing the risk of developing a cytokine storm in immuno-oncology.

Zenodo (CERN European Organization for Nuclear Research)
Nalu Scientific (United States) (US)
Good health and well-being
Openalex Percentile: Top 48%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Causes and methods of preventing cytokine storm in immuno-oncology · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS